Phase 2 Blood Glucose Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Does exogenous glucose-dependent insulinotropic polypeptide (GIP) effect gastric emptying and glycaemic response to small intestinal nutrient in critically ill patients?
Blood Glucose Control
Adam Deane25 enrolled1 locationACTRN12612000488808
Completed
Phase 2Phase 3
Clinical trial of a Chinese herbal medicine for the treatment of prediabetes and mild diabetes
Mild diabetes defined as those with diabetes diagnosed within 5 yrs of enrolment in the clinical trial, diet and exercise controlled and not taking any medications.Impaired glucose tolerance defined as having a fasting blood glucose <7.8 mmol and a 2 hour post prandial blood glucose >7.8 but <11.00
Xiyuan Hospital100 enrolled1 locationACTRN12612000128897
Completed
Phase 2
Does exogenous glucose-dependent insulinotropic polypeptide (GIP) in combination with glucagon-like peptide-1 (GLP-1) attenuate the glycaemic response to small intestinal nutrient in critically ill patients?
Blood Glucose
Adam Deane20 enrolled1 locationACTRN12611000735954
Completed
Phase 2
Does exogenous glucagon-like peptide-1 (GLP-1) attenuates the glycaemic response to small intestinal nutrient in critically ill patients with pre-existing type-2 diabetes?
Blood Glucose
Adam Deane10 enrolled1 locationACTRN12610000185066
Completed
Phase 2
Exogenous glucagon-like peptide-1 (GLP-1) attenuates the glycaemic response to small intestinal nutrient in the critically ill.
Blood Glucose
Adam Deane8 enrolled1 locationACTRN12609000093280